Pharming Group N.V. Profit Margin

The latest profit margin for PHGUF is 6.22% as of September 2026. That compares with 0.1% in the prior-year period — up 6433.8% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Pharming Group N.V.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PHGUF's profit margin moved from 0.1% to 6.22% — a 6433.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pharming Group N.V.'s valuation or profitability profile.

Against Healthcare companies, PHGUF currently prints 6.22% for profit margin, while the sector average sits near 9.48%. That is roughly 34.4% below the sector mean. Large gaps often invite a closer look at Pharming Group N.V.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Pharming Group N.V. converts resources into returns. At 6.22%, PHGUF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 0.1% in the prior-year period — up 6433.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PHGUF's profit margin (6.22%), review year-over-year change from 0.1%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.